-- GSK invites private equity bids for older drugs -sources
-- By Ben Hirschler
-- Thu May 29, 2014 11:09AM EDT
-- None



LONDON, May 29 (Reuters) - GlaxoSmithKline <GSK.L> has invited private equity firms to consider making offers for a range of its older drugs, according to two people with direct knowledge of the matter.

The move is part of a reshaping of the drugmaker's business, which also involves a major asset swap deal with Novartis <NOVN.VX>.